Extended-release triamcinolone acetonide (FX006) versus placebo in knee osteoarthritis treatment
Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational StudyJ Bone Joint Surg Am. 2018 Apr 18;100(8):666-677
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
486 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized to one of three groups: single intraarticular injection of 32mg extended-release triamcinolone (FX006; Flexion Therapeutics); single intraarticular injection of 40mg triamcinolone acetonide crystalline suspension (TAcs); or single intraarticular injection of placebo saline. Patients were assessed primarily with re...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE